Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 131.00
High: 133.00
Low: 131.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

10 Jun 2020 08:32

RNS Number : 5138P
Nationwide Building Society
10 June 2020
 

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR TO ANY U.S. PERSON OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT

 

Nationwide Building Society announces proposed offering of Additional Tier 1 Securities and proposed issue of Core Capital Deferred Shares

 

10 June 2020. Nationwide Building Society (the "Society") is today launching a proposed offering, subject to customary offer restrictions, of sterling-denominated reset perpetual contingent convertible additional tier 1 securities (the "AT1 Securities"). The offer of the AT1 Securities is expected to price later today and to settle on or around 17 June 2020. The Society has appointed Citigroup Global Markets Limited, J.P. Morgan Securities plc, Merrill Lynch International and Morgan Stanley & Co. International plc as joint bookrunners (the "Joint Bookrunners") in connection with the offering of the AT1 Securities. The net proceeds of the issue of the AT1 Securities will be used by the Society to strengthen its regulatory capital base and for general business purposes consistent with the Society's principal purpose as a UK building society.

The Society has also separately agreed to issue 28,000 new Core Capital Deferred Shares ("CCDS") at an issue price of £162.041 per CCDS. The new CCDS are expected to be issued on or around 17 June 2020, and will be consolidated and form a single series with the Society's 10,500,000 CCDS currently outstanding. The net proceeds of the issue of the CCDS will be used to strengthen the Society's regulatory capital base, to satisfy prudential requirements with respect to discretionary awards and for general business purposes consistent with the Society's principal purpose as a UK building society.

For further information, please contact:

Alex Wall

Head of Financial Risk & Resource Optimisation

Telephone: +44 (0) 20 7261 6568

Email: Alexander.Wall@nationwide.co.uk

Nationwide Building Society

One Threadneedle Street

London EC2R 8AW

-----

DISCLAIMER

No representation has been made that any action has been or will be taken by the Society or any of the Joint Bookrunners that would permit a public offer of the securities referred to herein (the "Securities"), or possession or distribution of this announcement or any offering materials relating to the Securities (in preliminary, proof or final form) or any other offering or publicity material relating to the Securities (including roadshow materials and investor presentations) in any country or jurisdiction where action for that purpose is required. The Securities may not be, directly or indirectly, offered or sold in any country or jurisdiction where action for that purpose is required. Accordingly, the Securities may not, directly or indirectly, be offered or sold, and neither this announcement nor any offering materials relating to the Securities may be distributed in or from, or published in, any country or jurisdiction, except under circumstances that will result in compliance with any applicable laws and regulations.

United States. The Securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state or other jurisdiction of the United States and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except in certain transactions exempt from the registration requirements of the Securities Act.

Prohibition of sales to UK and EEA Retail Investors. The Securities have not been, and will not be, offered, sold or otherwise made available to any retail investor in the United Kingdom or the European Economic Area. For the purposes of this provision the expression "retail investor" means a person who is one (or more) of (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II") or (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II.

United Kingdom. This announcement and any offering materials relating to the Securities are directed only at, and will be distributed only to, (i) persons who are outside the United Kingdom, (ii) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 or (iii) those persons to whom it may otherwise lawfully be distributed (all such persons together being referred to as "relevant persons"). This announcement or any offering materials relating to the Securities is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity in relation to the Securities is available only to relevant persons and will be engaged in only with relevant persons. Any offering materials relating to the Securities will only be communicated to persons in the United Kingdom in circumstances where section 21(1) of the Financial Services and Markets Act 2000 would not, if the Society was not an authorised person, apply to the Society.

Additional offer and distribution restrictions apply in relation to the Securities in Italy, Canada and Singapore and may apply in other jurisdictions. The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement come are required by the Society and each of the Joint Bookrunners to inform themselves about, and to observe, any such restrictions. Nothing in this announcement constitutes an offer or sale of any Securities or a solicitation of an offer to purchase any Securities.

Compliance information for the Securities: MiFID II product governance - eligible counterparties and professional clients only; PRIIPs Regulation/FCA CoCo restriction/COBS 22.2 - no sales to United Kingdom or European Economic Area retail investors; no key information document has been or will be prepared.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFMMRTMTJBMBM
Date   Source Headline
20th Jul 20223:22 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
14th Jul 20223:43 pmRNSResult of AGM
12th Jul 20229:29 amRNSPre Stabilisation Notice - Nationwide Building Soc
24th Jun 202210:45 amRNSPublication of a Prospectus
10th Jun 20227:30 amRNSResolvability Assessment Framework
9th Jun 20224:56 pmRNSFurther re Tender Offer
25th May 20223:01 pmRNSTender Offer
20th May 202212:44 pmRNSPublication of Supplemental Prospectus
20th May 20227:00 amRNSAnnual Financial Report
16th May 20222:21 pmRNSPublication of Final Terms
26th Apr 20226:00 pmRNSPublication of Final Terms
5th Apr 20224:10 pmRNSRedemption of Notes
1st Apr 20229:00 amRNSDirectorate Change
1st Mar 20229:00 amRNSBoard Changes
25th Feb 20223:19 pmRNSPublication of a Prospectus
15th Feb 20229:23 amRNSPublication of Final Terms
15th Feb 20229:23 amRNSPublication of Final Terms
28th Jan 20228:00 amRNSBoard Changes
14th Dec 20217:00 amRNSResponse to Results of BoE Stress Test 2021
10th Dec 20211:51 pmRNSPublication of Base Prospectus
10th Dec 20211:41 pmRNSPublication of Base Prospectus
3rd Dec 20218:00 amRNSLeadership Succession
19th Nov 202111:13 amRNSPublication of Suppl.Prospcts
19th Nov 20217:00 amRNSHalf-year Report
29th Oct 20213:34 pmRNSPublication of a Prospectus
19th Oct 20217:00 amRNSPermanent Interest Bearing Shares Call Notice
11th Oct 20214:23 pmRNSPublication of Final Terms
23rd Sep 20219:00 amRNSLeadership Succession
10th Sep 20215:36 pmRNSPublication of Final Terms
22nd Jul 20212:49 pmRNSResults of AGM and Board changes
7th Jul 20211:57 pmRNSResult of Meeting
29th Jun 202112:15 pmRNSPublication of a Base Prospectus
3rd Jun 202111:00 amRNSCirc re. Notice of Meeting
3rd Jun 202110:59 amRNSTender Offer and Consent Solicitation
24th May 20211:53 pmRNSPublication of Suppl.Prospcts
21st May 20217:00 amRNSAnnual Financial Report
5th May 20212:06 pmRNSPublication of Final Terms
1st Apr 20219:46 amRNSPublication of Suppl.Prospcts
1st Mar 20216:05 pmRNSPublication of Final Terms
1st Mar 20211:00 pmRNSAppointment of Non-Executive Director
12th Feb 20216:03 pmRNSPublication of a Prospectus
22nd Jan 202110:39 amRNSPublication of Final Terms
7th Jan 202112:32 pmRNSPublication of a Prospectus
16th Dec 202010:33 amRNSPublication of Final Terms
8th Dec 202012:47 pmRNSHolding(s) in Company
8th Dec 202012:46 pmRNSInitial admission - Offcl Lst
1st Dec 202012:17 pmRNSIssue of Equity
20th Nov 20204:08 pmRNSPublication of Suppl.Prospcts
20th Nov 20207:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.